Old Web
English
Sign In
Acemap
>
authorDetail
>
Penny Currykosky
Penny Currykosky
University of Texas Southwestern Medical Center
Medicine
Clinical trial
Cancer
Pathology
Cancer research
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Improving the Time to Activation of New Clinical Trials at a National Cancer Institute–Designated Comprehensive Cancer Center
2020
Journal of Oncology Practice
Erin L. Williams
Timothy J. Brown
Patrice Griffith
Asal Rahimi
Rhonda Oilepo
Hans J. Hammers
Theodore W. Laetsch
Penny Currykosky
Susan Partridge
Muhammad Shaalan Beg
Show All
Source
Cite
Save
Citations (2)
Applying quality improvement methodologies to decrease the time-to-activation of new clinical trials at an NCI-designated comprehensive cancer center.
2019
Journal of Clinical Oncology
Timothy J. Brown
Erin Fenske Williams
Patrice Griffith
Asal Rahimi
Rhonda Oilepo
Hans J. Hammers
Theodore W. Laetsch
Pamela Kurian
Penny Currykosky
Susan Partridge
Muhammad Shaalan Beg
Show All
Source
Cite
Save
Citations (0)
A phase 1/2 dose escalation and expansion study of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated non-squamous NSCLC.
2018
Journal of Clinical Oncology
Sawsan Rashdan
Jessica N. Williams
Penny Currykosky
Farjana Fattah
Jonathan Padro
Katarzyna Wnuk-Lipinska
Gro Gausdal
Anthony Brown
David R. Micklem
Robert J. Holt
James B. Lorens
Murray Yule
David E. Gerber
Show All
Source
Cite
Save
Citations (1)
1